AI assistant
Astera Labs, Inc. — Director's Dealing 2024
Nov 18, 2024
30120_dirs_2024-11-18_9ac2d598-845a-4cb2-8387-896c02a1b2b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Astera Labs, Inc. (ALAB)
CIK: 0001736297
Period of Report: 2024-11-14
Reporting Person: Tate Michael Truett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-14 | Common Stock | A | 694 | $30.60 | Acquired | 293822 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1762888 | Indirect |
Footnotes
F1: These shares were acquired under the Astera Labs, Inc. 2024 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2: These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.